Fintel revises target for Auxly Cannabis Group stock to USD 4.59

Auxly Cannabis Group (CA05335P7039) received a revised average one-year target of USD 4.59 from USD 4.08 on September 29, 2026, as Fintel reported. The target revision gives the latest analyst consensus a clear numerical catalyst while the company continues to build its Canadian cannabis portfolio.

Revenue grows in the second quarter

Auxly reported CAD 45.8 million in revenue for the second quarter of 2026, an 18.00 percent increase from the same quarter of 2025, according to SquawkNews. Adjusted EBITDA rose 24.00 percent to CAD 14.3 million, and gross margin reached 55.00 percent compared with 52.00 percent in the second quarter of 2025.

The operating figures matter because the company paired revenue growth with cash generation. Cash from operations reached CAD 4.2 million in the second quarter of 2026, while the balance sheet held CAD 38.8 million in cash at June 30, 2026.

Target rises above the prior estimate

Fintel's revised USD 4.59 average target stands 12.50 percent above the prior USD 4.08 estimate. Its review covered five recommendations for the September 1, 2026 period, with four positive ratings and one hold, according to Fintel.

The target revision sits alongside a longer-term capacity plan. Auxly's second-quarter call described a CAD 30.0 million program through 2028 designed to lift yield at its Leamington operation by 30.00 percent from 2025 levels, with CAD 10.0 million to CAD 12.0 million earmarked for 2026, as SquawkNews reported.

Prior close anchors the euro view

The prior close at Lang & Schwarz was EUR 2.12 on October 5, 2026. Auxly's investor page identifies the listing as TSX:XLY and dates the second-quarter results release August 13, 2026.

The further course of trading is shown by the continuously updated real-time quote of Auxly Cannabis Group stock.

More news and analyses on Auxly Cannabis Group stock